

Phone (Mobile)
+1 905 ❅❅❅ ❅❅❅❅
Phone (Mobile)

Phone (HQ)
+41 616881111
Phone (HQ)

❅❅❅❅❅@gmail.com

Office Address (HQ)
Grenzacherstrasse 124, Basel, Basel-City, 4070, Switzerland
Office Address (HQ)
Get 10 Free Leads on us
Use our Chrome Extension & instantly connect with prospects
Harman Gill
According to Datanyze information, these are Harman Gill's contact details. Reveal the hidden information below for FREE!
Phone (Mobile)
+1 905 ❅❅❅ ❅❅❅❅
Phone (Mobile)
Phone (HQ)
+41 616881111
Phone (HQ)
❅❅❅❅❅@gmail.com
Office Address (HQ)
Grenzacherstrasse 124, Basel, Basel-City, 4070, Switzerland
Office Address (HQ)
Harman Gill works as a Regulatory Associate & Program Director at Roche, which is a Manufacturing company with an estimated 103.6 K employees; and founded in 1896. They are part of the Corporate Strategy team within the Operations Department and their management level is Director. Harman graduated from Seneca College of Applied Arts and Technology and is currently based in Mississauga, Canada. They used to work at Roche and Purdue Pharma and have used the following emails: , @modernatx.com.
This is all just the tip of the iceberg. Get to know Harman better today! ❄️
Harman Gill's career began less then a year ago. Prior to joining Roche, Harman worked at 7 companies.
Science Senior Manager, Regulatory (CMC)
Product Manager, Regulatory
Regulatory Affairs Associate
Analytical Chemist II
Analytical Chemist I
Laboratory Technician
Assembler
Bachelor of Science (BSc)
Ryerson University
Certificate
Seneca College of Applied Arts and Technology
Roche
Grenzacherstrasse 124, Basel, Basel-City, 4070, Switzerland
103.6 K
$71.1 B
Manufacturing, Pharmaceuticals, Business Services, Research & Development
Get Full Profile Access
Ice Breakers
Imagine you could know all about Roche - Harman Gill’s company, before you contact them. Warm up a cold prospect with Datanyze icebreakers
Harman’s company in the news
FDA approves Roche’s Susvimo for diabetic retinopathy
May 22, 2025
Roche provides update on FDA Advisory Committee meeting on Columvi combination for people with relapsed or refractory diffuse large B-cell lymphoma
May 20, 2025
Roche receives FDA approval for the VENTANA MET (SP44) RxDx Assay as the first companion diagnostic to identify non-squamous non-small cell lung cancer patients eligible for treatment with Emrelis
May 14, 2025
See more
Insights to Break the Ice
In your first interaction
Harman is located in Canada
LightCycler® 480 by Roche is used by 1 companies
Work Colleague
See Harman Gill's coworkers out of Roche's 103.6 K employees